Di Wang
No.127 Changle West Road
Xi'an, 710032, China
Xi'an, 710032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Enhancing prognostic guidance in renal light-chain amyloidosis: a new staging system incorporating pathological characters.
Journal: International urology and nephrology
Published: July 01, 2024
Phosphorylation of KRT8 (keratin 8) by excessive mechanical load-activated PKN (protein kinase N) impairs autophagosome initiation and contributes to disc degeneration.
Journal: Autophagy
Published: March 10, 2023
SIRT5-related desuccinylation modification of AIFM1 protects against compression-induced intervertebral disc degeneration by regulating mitochondrial homeostasis.
Journal: Experimental & molecular medicine
Published: September 01, 2022
Targeting clock-controlled gene Nrf2 ameliorates inflammation-induced intervertebral disc degeneration.
Journal: Arthritis research & therapy
Published: May 31, 2022
Diagnostic value of electron microscopy detection using abdominal fat pad biopsy in systemic amyloidosis.
Journal: Clinical nephrology
Published: January 12, 2021
Implant Preservation versus Implant Replacement in Revision Surgery for Adjacent Segment Disease After Thoracolumbar Instrumentation: A Retrospective Study of 43 Patients.
Journal: World neurosurgery
Published: December 29, 2020
A comparative study of cyclophosphamide, thalidomide and dexamethasone (CTD) versus bortezomib and dexamethasone (BDex) in light-chain amyloidosis.
Journal: Current problems in cancer
Published: August 11, 2020
The efficacy and safety of bortezomib-based chemotherapy for immunoglobulin light chain amyloidosis: A systematic review and meta-analysis.
Journal: European journal of internal medicine
Published: June 16, 2019
Progerin accumulation in nucleus pulposus cells impairs mitochondrial function and induces intervertebral disc degeneration and therapeutic effects of sulforaphane.
Journal: Theranostics
Published: October 14, 2018
Cyclophosphamide + Thalidomide + Dexamethasone Versus Melphalan + Dexamethasone for the Treatment of Amyloid Light-chain Amyloidosis With Kidney Involvement: A Retrospective Study in Chinese Patients.
Journal: Clinical therapeutics
Published: September 28, 2018
Showing 1-12 of 12
Last Updated: 09/26/2026